FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to pharmaceutics, namely to a method for stimulating growth of L. Crispatus relative to E. coli in the urogenital region of a patient. Method for stimulating the growth of L. Crispatus relative to E. coli in the urogenital region of a patient in need thereof, so that the therapeutic effect is more than 30, wherein the method comprises the local introduction into the urogenital region of the patient of a composition comprising one therapeutic agent, which is isomaltulose, and an aqueous solvent, wherein the content of one therapeutic agent is 0.1 to 2.0 wt./vol.% of the composition.
EFFECT: above-described method provides stimulation of growth of Lactobacillus Crispatus relative to Escherichia coli in urogenital area of patient in need thereof, so that therapeutic effect is more than 30.
5 cl, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR MAINTENANCE OF LACTOBACTERIA DOMINATION | 2015 |
|
RU2723015C2 |
| SYNERGISTIC COMPOSITION FOR MAINTAINING HEALTHY MICROFLORA BALANCE | 2015 |
|
RU2709464C2 |
| SYNERGIC COMPOSITION TO MAINTAIN HEALTHY BALANCE OF MICROFLORA | 2017 |
|
RU2748651C2 |
| USE OF THIOSULPHATE IN ORDER TO POTENTIATE ANTI-PATHOGEN EFFECT OF LACTOBACILLUS | 2013 |
|
RU2667122C2 |
| COMPOSITIONS AND METHODS OF PREVENTING OR TREATING URINARY INCONTINENCE, BLADDER OVERACTIVITY OR MENSTRUAL CRAMPS | 2019 |
|
RU2808470C2 |
| AGENT FOR INTRAVAGINAL DELIVERY OF ACTIVE COMPONENT, METHOD OF PRODUCTION AND USE OF THE MEDICINAL PRODUCT | 2022 |
|
RU2806114C2 |
| BACTERIUM LACTOBACILLUS RHAMNOSUS FOR THE TREATMENT OF, FOR EXAMPLE, BACTERIAL VAGINOSIS | 2016 |
|
RU2758109C2 |
| PROBIOTIC STRAINS Lactobacillus AND THEIR CONSORTIUM FOR PROPHYLAXIS AND TREATMENT OF UROGENITAL INFECTIOUS DISEASES OF FEMALES | 2012 |
|
RU2504580C1 |
| COMPOSITION AND METHOD TO CONTROL AND MAINTAIN BACTERIAL MICROFLORA AND ACIDITY OF VAGINA | 2006 |
|
RU2409368C2 |
| LACTOBACILLUS CRISPATUS STRAIN FOR TREATMENT OR PREVENTION OF SEXUAL AND UROGENITAL INFECTIONS, SUCH AS VAGINOSIS AND CANDIDIASIS, AND USE THEREOF | 2013 |
|
RU2661102C2 |
